Overview | Research directions | Group members | Collaborations | Selected Publications


RNA-binding proteins (RBPs) and their impact on gene expression have long been studied in isolation. However, considering one RBP at a time leads to models of post-transcriptional regulation of gene expression that are unable to account for the sheer complexity of this regulatory layer. The main focus of the laboratory is thus to study the concurrent action of multiple RBPs by modeling post-transcriptional regulatory networks through computational and molecular biology tools. We are particularly interested in exploring the cooperative and competitive interplay of RNA-binding proteins, and how alterations of these mechanisms affect the onset and progression of cancer.

Research directions

Patterns of RBP interplay: Understanding if and how two RNA-binding proteins compete or cooperate will allow us to describe the effect of these interactions on their RNA targets and the related cellular processes. We design and implement algorithms to identify RBP interplay patterns by taking advantage of state of the art machine learning methods applied to transcriptome-wide protein-RNA interaction and expression datasets.

Post-transcriptional networks in pancreatic adenocarcinoma: Pancreatic ductal adenocarcinoma is a lethal disease, with a 5% survival rate and rising incidence. The lack of effective cures calls for innovative treatment strategies. Post-transcriptional regulation of gene expression is broadly altered in this tumor: we analyze genetic alterations to RNA-binding proteins and study their consequences on post-transcriptional networks with the long-term goal to develop novel, interplay-based, therapeutic options for this disease.

Epitranscriptomic networks in cancer: RNA modifications have emerged as a complex facet of post-transcriptional regulation. We analyze high-throughput RNA modification datasets and predict the cooperation and competition of the enzymes writing, reading, and erasing these marks, both within a modification and across different modification types. We use this knowledge to study how alterations to such mechanisms can affect the progression of cancer.

Group members

  • Erik Dassi, PI
  • Eliana Destefanis, PhD student (co-mentored with Prof. Alessandro Quattrone)
  • Andrea Zen, BSc student
  • Emma Della Libera, BSc student


  • Stefania Millevoi, Cancer Research Centre of Toulouse, Toulouse, France
  • Francisca Aguilo, Wallenberg Center for Molecular Medicine, Umeå University, Umeå, Sweden
  • Lorenzo Montanaro, DIMES - University of Bologna, Bologna, Italy
  • Alberto Inga, Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy
  • Alessandro Quattrone, Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento, Italy

Selected publications